Literature DB >> 14647208

Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum.

Flavia de Paula1, Natássia Vieira, Alessandra Starling, Lydia Uraco Yamamoto, Bruno Lima, Rita de Cássia Pavanello, Mariz Vainzof, Vincenzo Nigro, Mayana Zatz.   

Abstract

Autosomal recessive limb-girdle muscular dystrophy linked to 19q13.3 (LGMD2I) was recently related to mutations in the fukutin-related protein gene (FKRP) gene. Pathogenic changes in the same gene were detected in congenital muscular dystrophy patients (MDC1C), a severe disorder. We have screened 86 LGMD genealogies to assess the frequency and distribution of mutations in the FKRP gene in Brazilian LGMD patients. We found 13 Brazilian genealogies, including 20 individuals with mutations in the FKRP gene, and identified nine novel pathogenic changes. The commonest C826A European mutation was found in 30% (9/26) of the mutated LGMD2I alleles. One affected patient homozygous for the FKRP (C826A) mutation also carries a missense R125H change in one allele of the caveolin-3 gene (responsible for LGMD1C muscular dystrophy). Two of her normal sibs were found to be double heterozygotes. In two unrelated LGMD2I families, homozygous for novel missense mutations, we identified four asymptomatic carriers, all older than 20 years. Genotype-phenotype correlation studies in the present study as well as in patients from different populations suggests that the spectrum of variability associated with mutations in the FKRP gene seems to be wider than in other forms of LGMD. It also reinforces the observations that pathogenic mutations are not always determinant of an abnormal phenotype, suggesting the possibility of other mechanisms modulating the severity of the phenotype that opens new avenues for therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14647208     DOI: 10.1038/sj.ejhg.5201066

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies.

Authors:  Xiaona Fu; Haipo Yang; Cuijie Wei; Hui Jiao; Shuo Wang; Yanling Yang; Chunxi Han; Xiru Wu; Hui Xiong
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

2.  Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I.

Authors:  Chiara A Boito; Marina Fanin; Bruno F Gavassini; Giovanna Cenacchi; Corrado Angelini; Elena Pegoraro
Journal:  Virchows Arch       Date:  2007-10-20       Impact factor: 4.064

3.  Frequency of the FKRP mutation c.826C>A in isolated hyperCKemia and in limb girdle muscular dystrophy type 2 in German patients.

Authors:  Frank Hanisch; Dörte Grimm; Stephan Zierz; Marcus Deschauer
Journal:  J Neurol       Date:  2009-10-10       Impact factor: 4.849

Review 4.  Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.

Authors:  Paul T Martin
Journal:  Nat Clin Pract Neurol       Date:  2006-04

5.  Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance.

Authors:  C Gaul; M Deschauer; C Tempelmann; S Vielhaber; H U Klein; H J Heinze; S Zierz; F Grothues
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

Review 6.  The dystroglycanopathies: the new disorders of O-linked glycosylation.

Authors:  Paul T Martin
Journal:  Semin Pediatr Neurol       Date:  2005-09       Impact factor: 1.636

7.  Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I.

Authors:  Marta Margeta; Anne M Connolly; Thomas L Winder; Alan Pestronk; Steven A Moore
Journal:  Muscle Nerve       Date:  2009-11       Impact factor: 3.217

8.  [The clinical spectrum of limb-girdle muscular dystrophies type 2I in cases of a mutation in the "fukutin-related- protein"-gene].

Authors:  M Krasnianski; S Neudecker; M Deschauer; S Zierz
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

Review 9.  Muscular dystrophies due to glycosylation defects.

Authors:  Francesco Muntoni; Silvia Torelli; Martin Brockington
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 10.  Muscular dystrophies due to defective glycosylation of dystroglycan.

Authors:  F Muntoni; M Brockington; C Godfrey; M Ackroyd; S Robb; A Manzur; M Kinali; E Mercuri; M Kaluarachchi; L Feng; C Jimenez-Mallebrera; E Clement; S Torelli; C A Sewry; S C Brown
Journal:  Acta Myol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.